BeOne Obtains Global Rights to Huahui Health’s Trispecifics For Up To $1.53bn

 
• By Xu Hu
  
Beijing Huahui Health out-licenses PD-1/CTLA-4/VEGF-A-targeted assets to BeOne (Shutterstock)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Deals

More from Business